{"id":139801,"date":"2023-06-07T15:28:09","date_gmt":"2023-06-07T09:58:09","guid":{"rendered":"https:\/\/www.gkseries.com\/blog\/?p=139801"},"modified":"2023-06-07T15:28:11","modified_gmt":"2023-06-07T09:58:11","slug":"unified-licensing-portal","status":"publish","type":"post","link":"https:\/\/www.gkseries.com\/blog\/unified-licensing-portal\/","title":{"rendered":"Unified Licensing Portal: UPSC Daily Important Topic | 6 June 2023"},"content":{"rendered":"\n<h3 class=\"wp-block-heading\">Unified Licensing Portal<\/h3>\n\n\n\n<p>The Central Bureau of Narcotics has launched a unified portal aimed at streamlining the licensing and authorization process for the pharma and chemical industry in India.<\/p>\n\n\n\n<p>\u2705 The portal has been developed with the goal of instilling efficiency, transparency, and accountability in the department&#8217;s operations while boosting the economy for Aatma Nirbhar Bharat and ensuring the availability of essential narcotic drugs and medicines to patients and their families.<\/p>\n\n\n\n<p>\u2705The portal will benefit drug exporters, importers, and manufacturers with easy and secure transactions, simplified processes, and contactless operations.<\/p>\n\n\n\n<p>\u2705 The portal is designed to be integrated with other government services, including Bharat Kosh,&nbsp; GST, PAN-NSDL validation, e-Sanchit, and UIDAI, providing single-point services for obtaining licenses from the Central Bureau of Narcotics.<\/p>\n\n\n\n<p>\u2705 The portal is an effective tool for striking a balance between the availability of these substances for medicinal, scientific, and industrial use while ensuring compliance with the law and preventing their diversion for illicit use.<\/p>\n\n\n\n<p>\u2705Central Bureau of Narcotics is a central government organization dealing with the international trade of Narcotic Drugs, Psychotropic Substances, and Precursor Chemicals under the ambit of various United Nations Conventions and the provisions of NDPS act 1985.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Unified Licensing Portal The Central Bureau of Narcotics has launched a unified portal aimed at streamlining the licensing and authorization process for the pharma and chemical industry in India. \u2705 The portal has been developed with the goal of instilling efficiency, transparency, and accountability in the department&#8217;s operations while boosting the economy for Aatma Nirbhar [&hellip;]<\/p>\n","protected":false},"author":894,"featured_media":139805,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1755],"tags":[1797],"class_list":["post-139801","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-upsc-important-topics","tag-upsc-daily-important-topic"],"_links":{"self":[{"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/posts\/139801","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/users\/894"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/comments?post=139801"}],"version-history":[{"count":1,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/posts\/139801\/revisions"}],"predecessor-version":[{"id":139807,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/posts\/139801\/revisions\/139807"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/media\/139805"}],"wp:attachment":[{"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/media?parent=139801"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/categories?post=139801"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/tags?post=139801"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}